Home Solexa

Solexa

acquired
IPO Delisting
Developer of Genetic Analysis Technology
Basic
Enterprise Profile

Basic Information

Solexa mainly engages in the development and commercialization of genetic analysis technologies in the United States and the United Kingdom. The company is developing and manufacturing the Solexa Genome Analysis System, which is based on its proprietary reversible terminator sequencing synthesis, chemistry, and clonal single-molecule array technology for DNA sequencing. Its platform is designed to support a range of analyses, including whole-genome resequencing, gene expression analysis, and small RNA analysis.
Solexa
California,United States of America
101~500 people
January 01, 1998
--
--

Enterprise Profile

Industrial Sector
Scientific Research and Experimental Development Services
Technology
Molecular Diagnostics Biotechnology Genetic Testing